Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.63 USD | +1.69% | +2.00% | -2.93% |
08/03 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
08/03 | AxoGen, Inc. Announces Executive Changes | CI |
Sales 2024 * | 179M 14.95B | Sales 2025 * | 201M 16.8B | Capitalization | 290M 24.16B |
---|---|---|---|---|---|
Net income 2024 * | -18M -1.5B | Net income 2025 * | -1M -83.38M | EV / Sales 2024 * | 1.62 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
-15.4
x | P/E ratio 2025 * |
-199
x | Employees | 427 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.93% |
Latest transcript on AxoGen, Inc.
1 day | +1.69% | ||
1 week | +2.00% | ||
Current month | -17.84% | ||
1 month | -14.67% | ||
3 months | -30.43% | ||
6 months | +77.75% | ||
Current year | -2.93% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Zaderej
CEO | Chief Executive Officer | 62 | 01/06/01 |
Nir Naor
DFI | Director of Finance/CFO | 50 | 06/12 |
Marc Began
CMP | Compliance Officer | 57 | 06/23/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Thomas
BRD | Director/Board Member | 68 | 30/20/30 |
Director/Board Member | 63 | 01/16/01 | |
John Johnson
BRD | Director/Board Member | 66 | 19/21/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 6.63 | +1.69% | 421,184 |
25/24/25 | 6.52 | -5.09% | 232,933 |
24/24/24 | 6.87 | -1.43% | 123,609 |
23/24/23 | 6.97 | +1.60% | 166,480 |
22/24/22 | 6.86 | +5.54% | 408,495 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.93% | 290M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AXGN Stock